SPIE buys Swiss life sciences engineering firm nimeg

  • SPIE acquired Switzerland-based life sciences engineering firm nimeg, expanding its industrial services footprint in the Swiss pharma and biotech facilities market.
  • nimeg, based in Baden-Dättwil, focuses on GMP engineering, planning, project management, and validation for EPCMV projects.
  • The target generated about EUR 5 million in revenue in 2025.
  • SPIE expects the deal to strengthen its ability to deliver larger end-to-end EPCMV projects in Switzerland.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SPIE SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607011145OMX_____CNEWS_EN_GNW1001210717_en) on July 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.